These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 23693020)
1. S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer. Onyeagucha BC; Mercado-Pimentel ME; Hutchison J; Flemington EK; Nelson MA Exp Cell Res; 2013 Aug; 319(13):2081-2090. PubMed ID: 23693020 [TBL] [Abstract][Full Text] [Related]
2. The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells. Mercado-Pimentel ME; Onyeagucha BC; Li Q; Pimentel AC; Jandova J; Nelson MA FEBS Lett; 2015 Aug; 589(18):2388-93. PubMed ID: 26193421 [TBL] [Abstract][Full Text] [Related]
3. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Fuentes MK; Nigavekar SS; Arumugam T; Logsdon CD; Schmidt AM; Park JC; Huang EH Dis Colon Rectum; 2007 Aug; 50(8):1230-40. PubMed ID: 17587138 [TBL] [Abstract][Full Text] [Related]
4. The induction of S100p expression by the Prostaglandin E₂ (PGE₂)/EP4 receptor signaling pathway in colon cancer cells. Chandramouli A; Mercado-Pimentel ME; Hutchinson A; Gibadulinová A; Olson ER; Dickinson S; Shañas R; Davenport J; Owens J; Bhattacharyya AK; Regan JW; Pastorekova S; Arumugam T; Logsdon CD; Nelson MA Cancer Biol Ther; 2010 Nov; 10(10):1056-66. PubMed ID: 20890108 [TBL] [Abstract][Full Text] [Related]
5. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma. Shen Z; Deng H; Fang Y; Zhu X; Ye GT; Yan L; Liu H; Li G Oncotarget; 2015 Aug; 6(24):20672-84. PubMed ID: 26009899 [TBL] [Abstract][Full Text] [Related]
6. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). Arumugam T; Simeone DM; Schmidt AM; Logsdon CD J Biol Chem; 2004 Feb; 279(7):5059-65. PubMed ID: 14617629 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma. Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699 [TBL] [Abstract][Full Text] [Related]
8. S100P: a novel therapeutic target for cancer. Arumugam T; Logsdon CD Amino Acids; 2011 Oct; 41(4):893-9. PubMed ID: 20509035 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of S100P, receptor for advanced glycation end products and ezrin in malignant melanoma. Zhu L; Ito T; Nakahara T; Nagae K; Fuyuno Y; Nakao M; Akahoshi M; Nakagawa R; Tu Y; Uchi H; Furue M J Dermatol; 2013 Dec; 40(12):973-9. PubMed ID: 24303922 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation and functional implication of S100P in cancer. Gibadulinova A; Tothova V; Pastorek J; Pastorekova S Amino Acids; 2011 Oct; 41(4):885-92. PubMed ID: 20155429 [TBL] [Abstract][Full Text] [Related]
11. S100P, a peculiar member of S100 family of calcium-binding proteins implicated in cancer. Tóthová V; Gibadulinová A Acta Virol; 2013; 57(2):238-46. PubMed ID: 23600880 [TBL] [Abstract][Full Text] [Related]
12. S100P promotes pancreatic cancer growth, survival, and invasion. Arumugam T; Simeone DM; Van Golen K; Logsdon CD Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848 [TBL] [Abstract][Full Text] [Related]
13. Aldose reductase inhibition prevents colon cancer growth by restoring phosphatase and tensin homolog through modulation of miR-21 and FOXO3a. Saxena A; Tammali R; Ramana KV; Srivastava SK Antioxid Redox Signal; 2013 Apr; 18(11):1249-62. PubMed ID: 22978663 [TBL] [Abstract][Full Text] [Related]
14. Targeting S100P inhibits colon cancer growth and metastasis by Lentivirus-mediated RNA interference and proteomic analysis. Jiang L; Lai YK; Zhang J; Wang H; Lin MC; He ML; Kung HF Mol Med; 2011; 17(7-8):709-16. PubMed ID: 21327297 [TBL] [Abstract][Full Text] [Related]
16. Structural insights into calcium-bound S100P and the V domain of the RAGE complex. Penumutchu SR; Chou RH; Yu C PLoS One; 2014; 9(8):e103947. PubMed ID: 25084534 [TBL] [Abstract][Full Text] [Related]
17. Persistent distention of colon damages interstitial cells of Cajal through Ca Yang S; Dong F; Li D; Sun H; Wu B; Sun T; Wang Y; Shen P; Ji F; Zhou D J Cell Mol Med; 2017 Sep; 21(9):1881-1892. PubMed ID: 28580775 [TBL] [Abstract][Full Text] [Related]
18. Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell. Jia ZC; Wan YL; Tang JQ; Dai Y; Liu YC; Wang X; Zhu J Int J Colorectal Dis; 2012 Apr; 27(4):437-45. PubMed ID: 22076613 [TBL] [Abstract][Full Text] [Related]
19. S100P acts as a target of miR-495 in pancreatic cancer through bioinformatics analysis and experimental verification. Jiang PF; Zhang XJ; Song CY; Zhang YX; Wu Y Kaohsiung J Med Sci; 2021 Jul; 37(7):562-571. PubMed ID: 33949774 [TBL] [Abstract][Full Text] [Related]
20. Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1. Xie ZY; Wang FF; Xiao ZH; Liu SF; Tang SL; Lai YL J Biochem; 2020 Jun; 167(6):557-564. PubMed ID: 32044957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]